Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch

A Sionna Therapeutics director sold 55,345 shares for total proceeds of $2.47 million at a weighted average price of $44.67 per share across April 17–18, 2026. The filing is a routine insider transaction and does not, by itself, indicate a change in company fundamentals.

Analysis

A Sionna Therapeutics director sold 55,345 shares for total proceeds of $2.47 million at a weighted average price of $44.67 per share across April 17–18, 2026. The filing is a routine insider transaction and does not, by itself, indicate a change in company fundamentals.